Concurrent with its IPO, Audeo Oncology will complete its demerger from Alchemia Limited where shares of
Audeo Oncology will be distributed to Alchemia Limited’s shareholders in a 1 (Audeo Oncology share): 37
(Alchemia Limited share) basis.
Concurrent with its IPO, Audeo Oncology will complete its...
Add to My Watchlist
What is My Watchlist?